Global data and analytics software company Quantexa has announced three new additions to their advisory board, including former CEO of NHSX Michael Gould.
Gould previously helped to launch the UK-Israel Technologies Hub with the aim of developing technology partnerships between companies from the two countries, and focused on “harnessing the power of data and technology to improve healthcare delivery” in his time with NHSX.
Quantexa has stated that Gould’s “deep expertise will help Quantexa identify the economies and industries for strategic focus and make decisions on commercial strategy”.
Gould himself comments: “It’s an exciting time for me to be joining Quantexa’s Advisory Board, at this critical stage of growth for the company. Quantexa’s innovative approach to helping customers in the private and public sectors make data their most valuable utility is revolutionising decision making across multiple industries. I look forward to working alongside the talented team at Quantexa to connect data and drive better outcomes for organisations.”
In addition to Gould, former director of GCHQ and former deputy head of MI5 Sir Jeremy Fleming is joining the advisory board, along with Ralph Schlosstein, former CEO of Evercore and former president of BlackRock.
Quantexa’s decision intelligence technology aims to “uncover hidden risk and new opportunities by providing a contextual, connected view of internal and external data in a single place”.
In 2020, we were delighted to welcome Matthew Gould to open the prestigious HTN Awards virtual ceremony, you can watch back here.
In other recruitment news, earlier this month we shared how Ronke Adejolu – previously NHS England’s national associate chief nursing information officer – is taking on a newly developed role as joint CXiO for Buckinghamshire, Oxfordshire and Berkshire West ICB and the NHS South East region.
We also covered the news that Shauna McMahon will be joining Newcastle upon Tyne Hospitals NHS Foundation Trust in January 2024 as their new chief information officer.
